An immunohistochemical study of the acute and long-term effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in the marmoset
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 23 (3) , 1025-1039
- https://doi.org/10.1016/0306-4522(87)90178-3
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- NEUROPEPTIDES AND DOPAMINE IN THE MARMOSETBrain, 1986
- Positron emission tomography after MPTP: observations relating to the cause of Parkinson's diseaseNature, 1985
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Failure of SKF 38393‐A to relieve parkinsonian symptoms induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the marmosetBritish Journal of Pharmacology, 1985
- VII. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985
- Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeysEuropean Journal of Pharmacology, 1984
- The use of L-DOPA in Parkinson's disease: a 20 year follow-upTrends in Pharmacological Sciences, 1981
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979